Digests

Decision Information

Decision Content

PATENTS

Infringement

Application seeking to prohibit Minister of Health from issuing notice of compliance in respect of proposed injectable ready‑to‑use Epirubicin Hydrochloride solution until expiry of Canadian Patent 1291037—Construction of claims, what phrase “not reconstituted from lyophilizate” referring to—Application allowed—Invention understood by ordinary person skilled in art as something not previously available to public.

Pfizer Canada Inc. v. Canada (Minister of Health) (T‑1142‑04, 2005 FC 1725, Hughes J., order dated 20/12/05, 34 pp.)

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.